Gentamicin Sulfate

Manufacturer
Cosette Pharmaceuticals, Inc. | Cosette Pharmaceuticals NC Laboratories, LLC
Effective date
2023-11-22
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-05-31 20:55:28

Label at a glance#

ProductGentamicin Sulfate
Active ingredientGENTAMICIN SULFATE
Label structure9 sections

Indications and uses

Primary skin infections: Impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. Secondary skin infections: Infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial super-infections of fungal or viral infections. Please Note: Ge...

Dosage and administration

A small amount of gentamicin sulfate cream should be applied gently to the lesions three or four times daily. The area treated may be covered with a gauze dressing if desired. In impetigo contagiosa, the crusts should be removed before application of gentamicin sulfate to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid further contamination of the infected skin. I...

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Gentamicin Sulfate Cream, USP 0.1% is a wide spectrum antibiotic preparation for topical administration. Each gram contains Gentamicin Sulfate USP equivalent to 1 mg gentamicin base in a cream base of isopropyl myristate, propylene glycol, propylene glycol monostearate, polysorbate 40, purified water, sorbitol solution and stearic acid. Preserved with butylparaben and methylparaben.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Gentamicin sulfate is a wide spectrum antibiotic that provides highly effective topical treatment in primary and secondary bacterial infections of the skin. Gentamicin Sulfate Cream may clear infections that have not responded to treatment with other topical antibiotic agents. In primary skin infections such as impetigo contagiosa, treatment 3 or 4 times daily with Gentamicin Sulfate Cream usually clears the lesions promptly. In secondary skin infections, Gentamicin Sulfate Cream aids in the treatment of the underlying dermatoses by controlling the infection. Bacteria susceptible to the action of gentamicin sulfate include sensitive strains of Streptococci (group A beta-hemolytic, alpha-hemolytic), Staphylococcus aureus (coagulase positive, coagulase negative, and some penicillinase-producing strains), and the gram-negative bacteria, Pseudomonas aeruginosa, Aerobacter aerogenes, Escherichia coli, Proteus vulgaris, and Kiebsiella pneumoniae.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Primary skin infections: Impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. Secondary skin infections: Infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial super-infections of fungal or viral infections. Please Note: Gentamicin sulfate is a bactericidal agent that is not effective against viruses or fungi in skin infections. Gentamicin sulfate is useful in the treatment of infected skin cysts and certain other skin abscesses when preceded by incision and drainage to permit adequate contact between the antibiotic and the infecting bacteria. Good results have been obtained in the treatment of infected stasis and other skin ulcers, infected superficial burns, paronychia, infected insect bites and stings, infected lacerations and abrasions, and wounds from minor surgery. Patients sensitive to neomycin can be treated with gentamicin sulfate, although regular observation of patients sensitive to topical antibiotics is advisable when such patients are treated with any topical antibiotic. Gentamicin Sulfate Cream, USP 0.1% is recommended for wet, oozing primary infections, and greasy, secondary infections, such as pustular acne or infected seborrheic dermatitis. If a water-washable preparation is desired, the cream is preferable. Gentamicin Sulfate Cream, USP 0.1% has been used successfully in infants over one year of age, as well as in adults and children.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

This drug product is contraindicated in individuals with a history of sensitivity to any of its components.

PRECAUTIONS

PRECAUTIONS SECTION

The use of topical antibiotics occasionally allows overgrowth of nonsusceptible organisms, including fungi. If this condition occurs, or if irritation, sensitization or superinfection develops, treatment with gentamicin sulfate should be discontinued and appropriate therapy instituted.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

In patients with dermatoses treated with gentamicin sulfate, irritation (erythema and pruritis) that did not usually require discontinuance of treatment has been reported in a small percentage of cases. There was no evidence of irritation or sensitization, however, in any of these patients patch-tested subsequently with gentamicin sulfate on normal skin. Possible photosensitization has been reported in several patients but could not be elicited in these patients by reapplication of gentamicin sulfate followed by exposure to ultraviolet radiation.

To report SUSPECTED ADVERSE REACTIONS, contact Cosette Pharmaceuticals, Inc. at 1-800-922-1038 or FDA at 1-800-FDA-1088 or www.fda.gov/ medwatch

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

A small amount of gentamicin sulfate cream should be applied gently to the lesions three or four times daily. The area treated may be covered with a gauze dressing if desired. In impetigo contagiosa, the crusts should be removed before application of gentamicin sulfate to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid further contamination of the infected skin. Infected stasis ulcers have responded well to treatment with gentamicin sulfate under gelatin packing.

HOW SUPPLIED

HOW SUPPLIED SECTION

Gentamicin Sulfate Cream, USP 0.1% is supplied in 15 gram tubes (0713-0683-15) and 30 gram tubes (0713-0683-31).


Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].


Distributed by:
Cosette Pharmaceuticals, Inc.
South Plainfield, NJ 07080


Rev. 05/2022
8-0683CPLNC2

VC7632

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0713-0683-15

Gentamicin Sulfate Cream, USP 0.1%

15 g

Rx only

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

Cosette Pharmaceuticals, Inc.

15 g Carton15 g Carton

NDC 0713-0683-31

Gentamicin Sulfate Cream, USP 0.1%

30 g

Rx only

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

Cosette Pharmaceuticals, Inc.

30 Carton30 Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
197735gentamicin sulfate 0.1 % Topical CreamPSN5
197735gentamicin 1 MG/ML Topical CreamSCD5
197735gentamicin (as gentamicin sulfate) 0.1 % Topical CreamSY5

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
GENTAMICIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3b7b3a7a-635f-32a3-0c6c-7ad028e3de91Product name220250107
43025f0d-698c-68da-cec9-ea4261a7ef7aProduct name220250107
d3946667-8212-d1f2-67e1-5643a329bb56Product name220200403
4ce5dce5-e8a7-e4f6-0059-b527e4307477Product name220190501
48b05f5d-d2fc-45ab-76e8-3cb5bd44890dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0713-0683-15Gentamicin Sulfate1 in 1 CARTONCREAM15
0713-0683-15Gentamicin Sulfate15 g in 1 TUBECREAM155
0713-0683-31Gentamicin Sulfate30 g in 1 TUBECREAM305
0713-0683-31Gentamicin Sulfate1 in 1 CARTONCREAM15

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0713-0683GENTAMICIN SULFATE CREAM [COSETTE PHARMACEUTICALS, INC.]5Current NDC, Legacy NDC, 4 package rows20231123_9e550dc9-509e-da05-8a97-ecbd0f5dd633.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0713-0683-15GM - Gram0713-068397942b5b-eb35-4f31-b99e-3e34fcc1165912017-03-06
0713-0683-31GM - Gram0713-06835b41e0d1-8044-4fbe-8687-7e2f1ea4e6ef12017-03-06

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0713-06830713-0683-15, 0713-0683-31

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A064056-001GENTAMICIN SULFATEGENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A064056-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-2984e616aacf4f…
2026-08-18 06:07:402026-07A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-2931067a03dcf5…
2025-08-23 18:47 UTC2025-08A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-296a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-2903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-292680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-295bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-2979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-291e350fbaab3a…
2024-05-31 18:47 UTC2024-05A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-298072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-295c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-295d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-294b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-2974a2ff9319b5…
2022-03-09 01:35 UTC2022-03A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-2987673890dc5c…
2021-03-12 10:30 UTC2021-03A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-295aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-298869cabd3fbd…
2020-11-12 02:37 UTC2020-11A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29c0c555d07b60…
2019-12-14 00:12 UTC2019-12A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-293f01610625f2…
2019-09-15 20:21 UTC2019-09A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29b00525d2431f…
2019-07-19 19:46 UTC2019-07A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-296a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-291c564ffb4f44…
2023-12-20 04:57 UTC2023-12A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-299b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-293f0d92c62455…
2023-05-13 08:27 UTC2023-05A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29053a50430f4f…
2023-01-26 05:58 UTC2023-01A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-293bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-293a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A064056-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALAT1994-04-29f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A064056-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A064056-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A064056-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A064056-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A064056-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A064056-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A064056-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A064056-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A064056-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A064056-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A064056-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A064056-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A064056-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A064056-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A064056-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A064056-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A064056-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A064056-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A064056-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A064056-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A064056-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A064056-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A064056-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A064056-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A064056-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A064056-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A064056-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A064056-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A064056-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A064056-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A064056-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A064056-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A064056-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A064056-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A064056-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A064056-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A064056-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A064056-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A064056-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A064056-001AT1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Gentamicin SulfateGENTAMICIN SULFATECosette Pharmaceuticals, Inc.9e550dc9-509e-da05-8a97-ecbd0f5dd6332023-11-22Adverse reactionsExact identifier
ndc (package): 0713-0683-15
ndc (package): 0713-0683-31
ndc (product): 0713-0683
ndc11 (package): 00713068331
ndc11 (package): 00713068315
spl id: 0abc5db4-9344-8946-e063-6394a90abf1c
spl set id: 9e550dc9-509e-da05-8a97-ecbd0f5dd633

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.